Research background · Updated November 1, 2026
ARA-290 Research: Publications, Study Types and Background
Short answer
ARA-290. As of November 1, 2026, PubMed indexes 37 records matching ARA-290, the earliest from 2012; 8 were published in 2021–2025 and 6 are reviews. ClinicalTrials.gov lists 4 registered studies matching the compound.
- PubMed records
- 37
- Earliest record
- 2012
- Published 2021–2025
- 8
- Reviews
- 6
- Animal-only studies
- 9
- Registered studies
- 4
Publications per year, 2006–2025
26 records in 2016–2025 against 14 in 2006–2015; the busiest year was 2014, with 5.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 0 |
| 2007 | 0 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 0 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 0 |
| 2025 | 1 |
Study types
| All PubMed records | 37 |
|---|---|
| Reviews | 616% |
| Animal studies (no human subjects indexed) | 924% |
| Indexed as clinical trials | 411% |
| Registered on ClinicalTrials.gov | 4 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent ARA-290 papers report, in their own authors’ terms. Each line links the paper it came from.
Erythropoietin receptor signaling and bone
In female mice given erythropoietin, adding cibinetide (ARA-290) reduced the number of osteoclast progenitors by 42.8% compared with erythropoietin alone.
MiceAwida Z 2021International journal of molecular sciencesPMID 35008482
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 37 of the 37 records. They describe what the literature is about, not what ARA-290 does.
- Neuralgia5 papers
- Sarcoidosis5 papers
- Diabetes Mellitus, Experimental4 papers
- Erythropoietin4 papers
- Cornea3 papers
- Cytokine Receptor Common beta Subunit3 papers
- Receptors, Erythropoietin3 papers
- Islets of Langerhans3 papers
Key papers
Earliest indexed record
Heij L (2012). Pain research and treatment.
PMID 23304492Most-cited paper · 109 citations
Brines M (2015). Molecular medicine (Cambridge, Mass.).
PMID 25387363Most-cited #2 · 87 citations
Heij L (2012). Molecular medicine (Cambridge, Mass.).
PMID 23168581Most-cited #3 · 79 citations
Culver DA (2017). Investigative ophthalmology & visual science.
PMID 28475703
Citation counts from NIH iCite, among the 37 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 1208243-50-8 |
|---|---|
| Molecular formula | C51H84N16O21 |
| Molecular weight | 1257.3 g/mol |
| Synonyms | Cibinetide, ARA290, PHBSP, PH-BSP, ARA-290 |
Identity data from PubChem, retrieved November 1, 2026, on the ARA-290 page.
How these numbers were counted
- PubMed search, run November 1, 2026:
"ARA-290"[tiab] OR "ARA 290"[tiab] OR cibinetide[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
"ARA-290" OR cibinetidere-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use ARA-290 outside a laboratory.
Wholesale supply
ARA-290, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
ARA-290 research questions
How much research has been published on ARA-290?
PubMed indexes 37 records matching ARA-290 (searched November 1, 2026), including 6 reviews and 4 records indexed as clinical trials. 8 were published in the five years 2021–2025.
When was ARA-290 first described in the literature?
The earliest PubMed record matching ARA-290 is from 2012 (Heij L, Pain research and treatment, PMID 23304492).
What topics does the ARA-290 literature cover?
The subject headings PubMed indexers most often marked as a main topic of ARA-290 papers are Neuralgia, Sarcoidosis, Diabetes Mellitus, Experimental, Erythropoietin. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is ARA-290 sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy ARA-290 wholesale for research?
We source ARA-290 to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.